| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases
|
Schlander, Michael
|
|
|
21 |
5 |
p. 525-531
|
artikel
|
| 2 |
Can Severity Outweigh Smaller Numbers? A Deliberative Perspective from Canada
|
Magalhaes, Monica
|
|
|
21 |
5 |
p. 532-537
|
artikel
|
| 3 |
Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group
|
Nestler-Parr, Sandra
|
|
|
21 |
5 |
p. 493-500
|
artikel
|
| 4 |
Challenges in Valuing Temporary Health States for Economic Evaluation: A Review of Empirical Applications of the Chained Time Trade-Off Method
|
Stoniute, Julija
|
|
|
21 |
5 |
p. 605-611
|
artikel
|
| 5 |
Clinical Outcome Assessments: Use of Normative Data in a Pediatric Rare Disease
|
Phillips, Dawn
|
|
|
21 |
5 |
p. 508-514
|
artikel
|
| 6 |
Copyright/Subscription
|
|
|
|
21 |
5 |
p. iii
|
artikel
|
| 7 |
Cost-Effectiveness of a Technology-Facilitated Depression Care Management Adoption Model in Safety-Net Primary Care Patients with Type 2 Diabetes
|
Hay, Joel W.
|
|
|
21 |
5 |
p. 561-568
|
artikel
|
| 8 |
Economic Modeling Considerations for Rare Diseases
|
Pearson, Isobel
|
|
|
21 |
5 |
p. 515-524
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
21 |
5 |
p. IFC
|
artikel
|
| 10 |
Evaluating and Valuing Drugs for Rare Conditions: No Easy Answers
|
Ollendorf, Daniel A.
|
|
|
21 |
5 |
p. 547-552
|
artikel
|
| 11 |
Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach
|
Ramos-Goñi, Juan M.
|
|
|
21 |
5 |
p. 596-604
|
artikel
|
| 12 |
Measurement Equivalence of Patient-Reported Outcome Measure Response Scale Types Collected Using Bring Your Own Device Compared to Paper and a Provisioned Device: Results of a Randomized Equivalence Trial
|
Byrom, Bill
|
|
|
21 |
5 |
p. 581-589
|
artikel
|
| 13 |
Mothers’ Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters: A Discrete Choice Experiment in Hong Kong
|
Wong, Carlos K.H.
|
|
|
21 |
5 |
p. 622-629
|
artikel
|
| 14 |
Patient Access to Medicines for Rare Diseases in European Countries
|
Detiček, Andreja
|
|
|
21 |
5 |
p. 553-560
|
artikel
|
| 15 |
Personal Income Before and After Diagnosis of Multiple Sclerosis
|
Landfeldt, Erik
|
|
|
21 |
5 |
p. 590-595
|
artikel
|
| 16 |
Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)
|
Stepanova, Maria
|
|
|
21 |
5 |
p. 612-621
|
artikel
|
| 17 |
Rare Diseases: Addressing the Challenges in Diagnosis, Drug Approval, and Patient Access
|
Copley-Merriman, Kati
|
|
|
21 |
5 |
p. 491-492
|
artikel
|
| 18 |
Setting the Boundaries for Economic Evaluation: Investigating Time Horizon and Family Effects in the Case of Postnatal Depression
|
Ride, Jemimah
|
|
|
21 |
5 |
p. 573-580
|
artikel
|
| 19 |
Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment Methods
|
Bourke, Siobhan M.
|
|
|
21 |
5 |
p. 538-546
|
artikel
|
| 20 |
Table of Contents
|
|
|
|
21 |
5 |
p. i-ii
|
artikel
|
| 21 |
The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries’ Health Economics Practitioners: A Commentary
|
Adeagbo, Chiaki Urai
|
|
|
21 |
5 |
p. 569-572
|
artikel
|
| 22 |
The Problem of Rarity: Estimation of Prevalence in Rare Disease
|
Auvin, Stéphane
|
|
|
21 |
5 |
p. 501-507
|
artikel
|
Tijdschrift beschrijving